Our panelists discuss best practices for:
- Evaluating whether there is enough reliable data to draw meaningful clinical study conclusions
- Assessing the status of each clinical study – what challenges and opportunities are presented based on study characteristics and timeline?
- Determining how studies can be designed now to build in future flexibility in schedules, procedures and analysis plans
- Leveraging DMCs/DSMBs to play a role in the assessment and modification of studies
- Revisiting safety data collection and reporting during the COVID-19 crisis
Don't trust your study to just anyone
WCG does DMCs right. Our experience, expertise, and personalized care helps sponsors organize, define, and gain insightful expertise to bridge from clinical trial to commercialization – and beyond. Experience the WCG difference starting with a free DMC services consultation.